Search Results Search Sort by RelevanceMost Recent Podcast Jun 2024 Author Interview: “When Should Patients at the End of Life Get Antimicrobials?” Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?” Policy Forum Feb 2005 What's Wrong with Quality of Life as a Clinical Tool? John S. Wyatt, MD, FRSPCH Some clinicians and researchers believe that quality-of-life measurements are flawed, and using them in clinical decision making is dangerous. Virtual Mentor. 2005; 7(2):183-186. doi: 10.1001/virtualmentor.2005.7.2.pfor1-0502. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. State of the Art and Science May 2006 Prostate Cancer Screening and Treatment Recommendations Nicholas J. Fitzsimons, MD and Stephen J. Freedland, MD Two physicians explore the issues surrounding prostate cancer diagnosis and treatment as they relate to obese men. Virtual Mentor. 2006; 8(5):323-326. doi: 10.1001/virtualmentor.2006.8.5.medu1-0605. State of the Art and Science Aug 2006 The ABCs of Melanoma: Expanding Basic Screening and Education Cory L. Simpson The basic guidelines for identifying a cutaneous melanoma are outlined. Virtual Mentor. 2006; 8(8):517-519. doi: 10.1001/virtualmentor.2006.8.8.cprl1-0608. Policy Forum May 2007 The Principle of Double Effect and Proportionate Reason Nicholas J. Kockler, MS, PhD The principle of double effect and proportionate reason can be a useful way of assessing actions as moral or immoral. Virtual Mentor. 2007; 9(5):369-374. doi: 10.1001/virtualmentor.2007.9.5.pfor2-0705. Personal Narrative Jan 2007 Surviving (and Thriving with) Cancer Brian Ciccotelli An interview with Brian Ciccotelli, a young cancer survivor, about his experiences with Hodgkin's disease. Virtual Mentor. 2007; 9(1):62-88. doi: 10.1001/virtualmentor.2007.9.1.mhum1-0701. Policy Forum Jan 2007 Setting Fair Prices for Life-Saving Drugs Bruce A. Chabner, MD and Thomas G. Roberts Jr, MD, MSocSci Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007; 9(1):38-43. doi: 10.1001/virtualmentor.2007.9.1.pfor1-0701. Policy Forum Jan 2007 Is It Ethical to Send Patients to Low-Volume Hospitals for Cancer Surgery? Timothy M. Pawlik, MD, MPH and Kenneth K. Tanabe, MD Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007; 9(1):44-47. doi: 10.1001/virtualmentor.2007.9.1.pfor2-0701. Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Next page Next › Last page Last »
Podcast Jun 2024 Author Interview: “When Should Patients at the End of Life Get Antimicrobials?” Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”
Policy Forum Feb 2005 What's Wrong with Quality of Life as a Clinical Tool? John S. Wyatt, MD, FRSPCH Some clinicians and researchers believe that quality-of-life measurements are flawed, and using them in clinical decision making is dangerous. Virtual Mentor. 2005; 7(2):183-186. doi: 10.1001/virtualmentor.2005.7.2.pfor1-0502.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
State of the Art and Science May 2006 Prostate Cancer Screening and Treatment Recommendations Nicholas J. Fitzsimons, MD and Stephen J. Freedland, MD Two physicians explore the issues surrounding prostate cancer diagnosis and treatment as they relate to obese men. Virtual Mentor. 2006; 8(5):323-326. doi: 10.1001/virtualmentor.2006.8.5.medu1-0605.
State of the Art and Science Aug 2006 The ABCs of Melanoma: Expanding Basic Screening and Education Cory L. Simpson The basic guidelines for identifying a cutaneous melanoma are outlined. Virtual Mentor. 2006; 8(8):517-519. doi: 10.1001/virtualmentor.2006.8.8.cprl1-0608.
Policy Forum May 2007 The Principle of Double Effect and Proportionate Reason Nicholas J. Kockler, MS, PhD The principle of double effect and proportionate reason can be a useful way of assessing actions as moral or immoral. Virtual Mentor. 2007; 9(5):369-374. doi: 10.1001/virtualmentor.2007.9.5.pfor2-0705.
Personal Narrative Jan 2007 Surviving (and Thriving with) Cancer Brian Ciccotelli An interview with Brian Ciccotelli, a young cancer survivor, about his experiences with Hodgkin's disease. Virtual Mentor. 2007; 9(1):62-88. doi: 10.1001/virtualmentor.2007.9.1.mhum1-0701.
Policy Forum Jan 2007 Setting Fair Prices for Life-Saving Drugs Bruce A. Chabner, MD and Thomas G. Roberts Jr, MD, MSocSci Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007; 9(1):38-43. doi: 10.1001/virtualmentor.2007.9.1.pfor1-0701.
Policy Forum Jan 2007 Is It Ethical to Send Patients to Low-Volume Hospitals for Cancer Surgery? Timothy M. Pawlik, MD, MPH and Kenneth K. Tanabe, MD Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007; 9(1):44-47. doi: 10.1001/virtualmentor.2007.9.1.pfor2-0701.